Plain-English translation of NCT05737732 on ClinicalTrials.gov ↗ · Source last updated · Translation generated · How we translate trials
Read our Multiple Myeloma research guide →This study doesn't follow the usual testing phases — it may be an observational study or a different type of research.
This trial is testing whether special lighting in hospital rooms can help patients with multiple myeloma who are undergoing a stem cell transplant recover better. The study compares two types of lighting: one designed to help your body's natural sleep-wake rhythm stay aligned, and another standard lighting. Researchers believe that keeping your circadian rhythm healthy during transplant may reduce fever, lower inflammation, improve sleep, and ease overall symptom burden.
Stem cell transplants are effective for myeloma but cause serious side effects, including fever, inflammation, and poor sleep. This treatment aims to address these complications by helping your body maintain its natural 24-hour rhythm during the hospital stay, which researchers believe could improve recovery and reduce complications.
You likely qualify if…
You likely don't qualify if…
Before your transplant, you'll wear a special activity tracker, carry a light meter, keep a sleep log, and provide urine and blood samples to measure your sleep hormones and inflammation levels. During your hospital stay for the transplant, your room will have either the special circadian lighting or standard lighting—you won't know which type you're receiving. You'll continue wearing the activity tracker and providing samples during transplant and once more four weeks after your transplant. Overall participation lasts about 2–3 months.
AI-generated summary from trial data · Jun 16, 2026 · Not medical advice
United States